D-1 / PD-L1 EXPRESSION IN INVASIVE BREAST CARCINOMA / CANCER
Objective: To investigate the immunohistochemical expression of PD-1 and PD-L1 in breast cancer cases and its correlation with clinicopathological factors. Study Design: Cross sectional study. Place and Duration of Study: Histopathology department, Armed Forces Institute of Pathology Rawalpind...
Guardado en:
Autores principales: | Sammeen Salim, Muhammad Asif, Rabia Ahmed, Muhammad Tahir Khadim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Army Medical College Rawalpindi
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5b387f8089e48a0a25701bf882e3a22 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Expression of Programmed Cell Death-1 (PD-1) and Its Ligand (PD-L1) in Breast Cancers and Its Association with Clinicopathological Parameters: A Study from North India
por: Anoushika Mehan, et al.
Publicado: (2021) -
Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
por: Chunyi Shen, et al.
Publicado: (2021) -
Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave
por: Xinfang Yu, et al.
Publicado: (2021) -
Inhibition of PI3Kδ Differentially Regulates Poly I:C– and Human Metapneumovirus–Induced PD–L1 and PD–L2 Expression in Human Bronchial Epithelial Cells
por: Tomohiro Ogawa, et al.
Publicado: (2021) -
Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer
por: Aurelia Noske, et al.
Publicado: (2021)